FMTX
Price:
$20.01
Market Cap:
$0
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8...[Read more]
Industry
Biotechnology
IPO Date
2020-06-19
Stock Exchange
NASDAQ
Ticker
FMTX
According to Forma Therapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -30.17%. This represents a change of 199.50% compared to the average of -10.07% of the last 4 quarters.
The mean historical ROE of Forma Therapeutics Holdings, Inc. over the last ten years is -9.46%. The current -30.17% ROE has changed 218.91% with respect to the historical average. Over the past ten years (40 quarters), FMTX's ROE was at its highest in in the March 2020 quarter at 6.68%. The ROE was at its lowest in in the December 2019 quarter at -15.85%.
Average
-9.46%
Median
-16.62%
Minimum
-34.71%
Maximum
30.10%
Discovering the peaks and valleys of Forma Therapeutics Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 219.52%
Maximum Annual ROE = 30.10%
Minimum Annual Increase = -174.32%
Minimum Annual ROE = -34.71%
| Year | ROE | Change |
|---|---|---|
| 2021 | -34.71% | 219.52% |
| 2020 | -10.86% | -51.44% |
| 2019 | -22.37% | -174.32% |
The current ROE of Forma Therapeutics Holdings, Inc. (FMTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.65%
5-year avg
-9.46%
10-year avg
-9.46%
Forma Therapeutics Holdings, Inc.’s ROE is greater than Verve Therapeutics, Inc. (-35.82%), greater than Crescent Biopharma, Inc. (-84.61%), greater than Gracell Biotechnologies Inc. (-37.93%), greater than VectivBio Holding AG (-56.92%), greater than Albireo Pharma, Inc. (-84.83%), less than EQRx, Inc. (14.15%), greater than Ethzilla Corp. (-192.62%), greater than Poseida Therapeutics, Inc. (-15.05%), greater than Avid Bioservices, Inc. (-44.35%),
| Company | ROE | Market cap |
|---|---|---|
| -35.82% | $994.04M | |
| -84.61% | $195.82M | |
| -37.93% | $989.87M | |
| -56.92% | $1.06B | |
| -84.83% | $915.89M | |
| 14.15% | $1.14B | |
| -192.62% | $126.43M | |
| -15.05% | $925.93M | |
| -44.35% | $798.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Forma Therapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Forma Therapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Forma Therapeutics Holdings, Inc.'s ROE?
How is the ROE calculated for Forma Therapeutics Holdings, Inc. (FMTX)?
What is the highest ROE for Forma Therapeutics Holdings, Inc. (FMTX)?
What is the 3-year average ROE for Forma Therapeutics Holdings, Inc. (FMTX)?
What is the 5-year average ROE for Forma Therapeutics Holdings, Inc. (FMTX)?
How does the current ROE for Forma Therapeutics Holdings, Inc. (FMTX) compare to its historical average?